Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

400
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
400
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

593
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
593
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

228
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
228
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

708
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
708
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

854
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
854

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Enteric populations of <i>Escherichia coli</i> are likely to be resistant to phages due to O antigen expression.

mSphere·2026
Same author

Bacteriophage Heteroresistance as a Cause of Treatment Failure in Urinary Tract Infections.

bioRxiv : the preprint server for biology·2026
Same author

Global trends in norovirus genotype distribution among medically attended children with acute gastroenteritis, 2020-2025.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026
Same author

High-resolution metabolomic analysis of stool reveals expanded biomarkers of <i>C. difficile</i> colitis and insights into pathophysiology.

Microbiology spectrum·2026
Same author

Fecal Microbiota Transplant for Multidrug Resistance-No Benefit Without Disruption?

JAMA internal medicine·2026
Same author

When probiotics guidelines differ: a practical guide for clinicians and researchers.

Gut microbes·2026

Video Experimental Relacionado

Updated: Jan 8, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.4K

Revisión del estado del arte: Diarrea infecciosa

Andi L Shane1, Mark D Gonzalez2, Amanda M Roy3

  • 1Division of Pediatric Infectious Disease, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|December 24, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Esta revisión describe un enfoque multidisciplinario para el manejo de la diarrea infecciosa, actualizando las pautas y discutiendo el diagnóstico, las manifestaciones y los tratamientos emergentes como los bioterapéuticos para reducir la carga de la enfermedad.

Palabras clave:
diagnósticodiarreainfecciosomanejoprevención

Más Videos Relacionados

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.4K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.5K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.4K
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.4K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.5K

Área de la Ciencia:

  • Enfermedades infecciosas; Gastroenterología; Microbiología; Farmacia Clínica

Sus antecedentes:

  • La diarrea infecciosa sigue siendo una preocupación importante para la salud con una epidemiología y etiologías en evolución.
  • Las pautas de 2017 de la Infectious Diseases Society of America proporcionan una base para el manejo.
  • Es crucial comprender el impacto individual y comunitario de la diarrea infecciosa.

Objetivo del estudio:

  • Presentar un enfoque multidisciplinario para el manejo de la diarrea infecciosa.
  • Destacar las actualizaciones en la epidemiología, etiologías y manifestaciones de la diarrea infecciosa.
  • Discutir los avances en el diagnóstico y las estrategias terapéuticas emergentes.

Principales métodos:

  • Revisión de la literatura actual y las pautas sobre diarrea infecciosa.
  • Integración de perspectivas de enfermedades infecciosas, gastroenterología, microbiología y farmacia.
  • Análisis de las modalidades de diagnóstico, incluidas las pruebas moleculares y basadas en cultivos.
  • Evaluación de la resistencia antimicrobiana emergente y las opciones bioterapéuticas.

Principales resultados:

  • La diarrea infecciosa se presenta con diversas manifestaciones agudas, crónicas y posinfecciosas.
  • Las pruebas de diagnóstico molecular (independientes de cultivo) y los métodos de cultivo tradicionales desempeñan un papel vital en el diagnóstico y la vigilancia.
  • La resistencia a los antimicrobianos es un desafío creciente en el manejo de la diarrea infecciosa.
  • Los bioterapéuticos ofrecen una estrategia prometedora para mitigar la carga de la diarrea infecciosa.

Conclusiones:

  • Un enfoque colaborativo y multidisciplinario es esencial para una atención óptima de la diarrea infecciosa.
  • La actualización de los conocimientos sobre epidemiología, diagnóstico y terapéutica es fundamental para un manejo eficaz.
  • Abordar la resistencia a los antimicrobianos y explorar los bioterapéuticos son direcciones futuras clave.